
|Videos|January 5, 2016
Q&A With Monika Fischer From Indiana University: Tackling New Challenges In Gastroenterology
Author(s)Amy Jacob
Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.
Advertisement
Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.
Monika Fischer, MD, from Indiana University discussed some of the latest research in this field during the annual meeting of the American College of Gastroenterology in Hawaii.
As fecal microbiota transplant becomes a more common procedure to treat patients with gastrointestinal issues new questions are being answered about factors that can affect its success.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Can We Stop Heart Failure at Its Source?
2
FDA Approves Furosemide Injection (Furoscix ReadyFlow) for Edema in HF, CKD
3
Sanofi Announces Discontinuation of Amlitelimab for Atopic Dermatitis
4
Q&A: How Is Precision Medicine Changing Atopic Dermatitis Care? With Jason Hawkes, MD
5










































































